You have no items in your shopping cart.
Search results for: 'Cov'
98.00%
134.36 kDa (predicted)
SARS-CoV-2
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) Spike Protein (S1+S2 ECD) (YP_009724390.1) (Val 16-Pro1213) was expressed with a polyhistidine tag at the C-terminus. Predicted N terminal: Val 16
C-His
100 μg98.00%
47.08 kDa (predicted)
SARS-CoV-2
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (YP_009724397.2(335Gly/Ala)) (Met1-Ala419) was expressed with a polyhistidine tag at the C-terminus. Predicted N terminal: Met 1
C-His
100 μg98.00%
51.5 kDa (predicted)
SARS-CoV-2
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) Spike Protein (RBD) (YP_009724390.1) (Arg319-Phe541) was expressed with the Fc region of mouse IgG1 at the C-terminus. Predicted N terminal: Arg319
C-mFc
100 μg98.00%
101.4 kDa (predicted)
SARS-CoV-2
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) spike protein S1 Subunit (YP_009724390.1) (Val16-Arg685) was expressed with the Fc region of mouse IgG1 at the C-terminus. Predicted N terminal: Val16
C-mFc
100 μg98.00%
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) spike protein S1 Subunit (YP_009724390.1) (Val16-Arg685) was expressed with a polyhistidine tag at the C-terminus. Predicted N terminal: Val16
C-His
100 μg98.00%
101.7 kDa (predicted)
SARS-CoV-2
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) spike protein S1 Subunit (YP_009724390.1) (Val16-Arg685) was expressed with the Fc region of human IgG1 at the C-terminus. Predicted N terminal: Val16
C-hFc
100 μg98.00%
76.6 kDa (predicted); 110.02 kDa (reducing condition, due to glycosylation)
SARS-CoV-2
A DNA sequence encoding the SARS-CoV-2 (XBB.1.16) Spike S1 (YP_009724390.1, with mutations T19I, V83A, G142D, H146Q, E180V, Q183E, V213E, G252V, G339H, R346T, L368I, V445P, G446S, N460K, S477N, T478R, E484A, F486P, F490S, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H) (Met1-Arg685) was expressed with a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant XBB.1.16). Predicted N terminal: Val 16
C-His
100 μg98.00%
136.74 kDa (predicted)
100 μg98.00%
136.74 kDa (predicted)
SARS-CoV-2
A DNA sequence encoding the SARS-CoV-2 (XBB.1.9.1) Spike S1+S2 (YP_009724390.1, with mutations T19I, L24S, del25-27, V83A, G142D, del144, H146Q, Q183E, V213E, G339H, R346T, L368I, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, V445P, G446S, N460K, S477N, T478K, E484A, F486P, F490S, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, F817P, A892P, A899P, A942P, Q954H, N969K, K986P, V987P and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant XBB.1.9.1). Predicted N terminal: Val 16
C-His
100 μg98.00%
27.04 kDa (predicted); 34.67 kDa (reducing condition, due to glycosylation)
SARS-CoV-2
A DNA sequence encoding the SARS-CoV-2 Spike RBD (YP_009724390.1, with mutation G339H, R346T, L368I, V445P, G446S, N460K, S477N, T478R, E484A, F486P, F490S, Q498R, N501Y, Y505H) (Arg319-lys529) was expressed with a C-terminal polyhistidine tag followed by an AVI tag. The expressed protein was biotinylated in vivo by the Biotin-Protein ligase (BirA enzyme) which is co-expressed. The mutations were identified in the SARS-CoV-2 variant (known as variant XBB.1.16). Predicted N terminal: Arg 319
C-His
100 μg
